Orbia Advance Corporation, S.A.B. de C.V. (BMV: ORBIA*) (“the Company” or “Orbia”) today released unaudited results for the ...
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life ...
MetLife, Inc. (NYSE: MET) today announced that Dan Glaser and Michelle Seitz were elected to its Board of Directors (the ...
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...
Zura Bio Limited (Nasdaq: ZURA), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating ...
Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious ...
The BRAFTOVI combination regimen is the only approved targeted regimen for first-line BRAF-V600E mutant metastatic colorectal cancerPivotal results from the Phase 3 portion with mFOLFOX6 of the ...
MEDFORD, MASSACHUSETTS / ACCESS Newswire / February 24, 2026 / Advanced Health Alliance, the behavioral health network behind Advanced Therapy Center, Advanced Addiction Center, Arya Therapy Center, ...
Phase III FDA trial for GelrinCAlready approved in Europe, GelrinC is expected to be rolled out in clinics across the continent in 2026GelrinC is positioned to be the ...
Today, the national law firm of Baron & Budd, together with co-counsel Diab Chambers LLP, announced a $38 million resolution with PG&E on behalf of six public entities relating to public and natural ...
Chinese partner Tonghua Dongbao completed BioChaperone® Lispro Phase 3 program with positive data on people with type 1 diabetes, completing the positive results obtained on type 2 diabetesContinued ...
Medincell (Euronext Paris: MEDCL), a commercial- and clinical-stage biopharmaceutical licensing company developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results